| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3906456 | Urology | 2007 | 5 Pages |
Abstract
The PSAV at the start of AIPC contributes prognostic information independent of the PSADT in patients receiving chemotherapy. Future studies should investigate the relative contribution of each of these factors in predicting survival.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Timothy J. Daskivich, Meredith M. Regan, William K. Oh,